Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in Critical Limb Ischemia
NCT02230527Phase 3Terminated
- Sponsor
- Cleveland Clinic
- Start
- Oct 2014
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ticagrelor in critical limb ischemia (CLI) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Absolute Change in TcPO2 From Baseline to Month 6. Started Oct 2014; status: terminated.
02
Drugs
ticagrelor
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02230527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230527.